Related Experiment Video
Updated: Dec 13, 2025
07:36
Analysis of Raw and Processed Cyperi Rhizoma Samples Using Liquid Chromatography-Tandem Mass Spectrometry in Rats with Primary Dysmenorrhea
Published on: December 23, 2022
1.8K
Maresins: anti-inflammatory pro-resolving mediators with therapeutic potential
1The First Clinical Medical College, Nanchang University, Nanchang, P.R. China. zhouxiaoyan@ncu.edu.cn.
European Review for Medical and Pharmacological Sciences
|July 25, 2020
Summary
Maresins, potent anti-inflammatory compounds derived from docosahexaenoic acid (DHA), help resolve inflammation. This review explores their mechanisms and therapeutic potential in various diseases.
Area of Science:
- Biomedical Science
- Lipid Mediator Research
- Inflammation Biology
Background:
- Inflammation is a protective response, but uncontrolled inflammation causes tissue damage and chronic conditions.
- Specialized pro-resolving mediators (SPMs), including maresins, are key to resolving inflammation.
- Maresins are novel lipid mediators derived from docosahexaenoic acid (DHA) by macrophages.
Purpose of the Study:
- To summarize the actions and mechanisms of maresins.
- To explore the therapeutic applications of maresins in various diseases.
Main Methods:
- Literature review of studies on maresins.
- Analysis of maresin biosynthesis and functions.
- Evaluation of maresin's role in different disease models.
Main Results:
- Maresins exhibit significant anti-inflammatory and pro-resolving activities.
- Maresins are synthesized from DHA by macrophages.
- Evidence suggests maresins have therapeutic potential across different diseases.
Conclusions:
- Maresins represent a promising class of therapeutic agents for inflammatory diseases.
- Further research into maresin mechanisms can unlock new treatment strategies.
- Targeting maresin pathways offers a novel approach to managing inflammation.
Related Concept Videos
01:28Inflammatory Response
15.5K
An inflammatory response is a localized, nonspecific immune reaction that occurs when a tissue is injured. It is characterized by redness, swelling, heat, and pain, which are commonly called the cardinal signs and symptoms of inflammation. Inflammation can sometimes result in a loss of function.
Inflammation can be triggered by various stimuli, such as impact, abrasion, chemical irritation, infections, and extreme hot or cold temperatures. These can damage cells and connective tissue fibers,...
Inflammation can be triggered by various stimuli, such as impact, abrasion, chemical irritation, infections, and extreme hot or cold temperatures. These can damage cells and connective tissue fibers,...
15.5K
01:24Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
351
Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab...
351
01:17Drugs Used in Lower Respiratory Disorders: Overview
892
Lower respiratory tract disorders present challenges that often require skilled and nuanced approaches for effective management. Common ailments, such as asthma and chronic obstructive pulmonary disease (COPD), have prompted the development of intricate treatment strategies involving bronchodilators and anti-inflammatory drugs, each tailored to ease breathing and revitalize the lungs.
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
892
01:29Inflammatory Bowel Disease IV: Pharmacological Management
341
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...
341
01:25Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
1.6K
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
1.6K
01:29Drugs for Treatment of Ulcerative Colitis in IBD
343
Ulcerative colitis is a chronic inflammatory condition primarily affecting the colon and rectum. The primary drugs used in the treatment of ulcerative colitis are aminosalicylates. They exhibit anti-inflammatory and immunosuppressive properties. They modulate inflammatory mediators and inhibit the activity of nuclear factor κB (NF-κB). Aminosalicylates also reduce inflammation by inhibiting prostaglandin and leukotriene production and decreasing neutrophil chemotaxis and superoxide...
343